300896 爱美客
交易中 11-26 13:10:30
资讯
新帖
简况
爱美客:产品具体上市时间需等待国家药监局审评结果
证券之星 · 11-20
爱美客:产品具体上市时间需等待国家药监局审评结果
海通国际:淘天品牌驱动、抖音套盒热销 双11化妆品龙头多平台增长
智通财经 · 11-20
海通国际:淘天品牌驱动、抖音套盒热销 双11化妆品龙头多平台增长
爱美客获得发明专利授权:“一种含有脱细胞生物组织材料的医用材料”
证券之星 · 11-16
爱美客获得发明专利授权:“一种含有脱细胞生物组织材料的医用材料”
爱美客(300896)11月8日股东户数6.29万户,较上期增加1.12%
证券之星 · 11-15
爱美客(300896)11月8日股东户数6.29万户,较上期增加1.12%
爱美客(300896)11月8日主力资金净卖出2.28亿元
证券之星 · 11-11
爱美客(300896)11月8日主力资金净卖出2.28亿元
海通国际:给予爱美客增持评级,目标价位299.47元
证券之星 · 11-10
海通国际:给予爱美客增持评级,目标价位299.47元
爱美客涨7.47%,德邦证券二个月前给出“买入”评级
证券之星 · 11-07
爱美客涨7.47%,德邦证券二个月前给出“买入”评级
“医美双雄”业绩承压:爱美客增速放缓,华熙生物变革阵痛
21世纪经济报道 · 11-04
“医美双雄”业绩承压:爱美客增速放缓,华熙生物变革阵痛
爱美客(300896)10月31日股东户数6.22万户,较上期增加0.3%
证券之星 · 11-04
爱美客(300896)10月31日股东户数6.22万户,较上期增加0.3%
天风证券:给予爱美客买入评级
证券之星 · 10-30
天风证券:给予爱美客买入评级
A股医美概念股局部异动,朗姿股份直线涨停,芭薇股份、爱美客、贝泰妮等短线拉升。
美港电讯 · 10-30
A股医美概念股局部异动,朗姿股份直线涨停,芭薇股份、爱美客、贝泰妮等短线拉升。
爱美客(300896)10月24日主力资金净卖出1.49亿元
证券之星 · 10-25
爱美客(300896)10月24日主力资金净卖出1.49亿元
国元证券:给予爱美客买入评级
证券之星 · 10-25
国元证券:给予爱美客买入评级
爱美客(300896)2024年三季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 10-25
爱美客(300896)2024年三季报简析:营收净利润同比双双增长,盈利能力上升
开源证券:给予爱美客买入评级
证券之星 · 10-24
开源证券:给予爱美客买入评级
民生证券:给予爱美客买入评级
证券之星 · 10-24
民生证券:给予爱美客买入评级
爱美客第三季度营收同比增长1.10% 多家券商下调业绩预测
立刻财经 · 10-24
爱美客第三季度营收同比增长1.10% 多家券商下调业绩预测
爱美客(300896.SZ)三季报业绩稳增、提质,长期增长潜力可观
格隆汇 · 10-24
爱美客(300896.SZ)三季报业绩稳增、提质,长期增长潜力可观
中邮证券:给予爱美客买入评级
证券之星 · 10-24
中邮证券:给予爱美客买入评级
东吴证券给予爱美客买入评级,2024三季报点评:收入增速放缓,单季度管理费用率明显下降
每日经济新闻 · 10-24
东吴证券给予爱美客买入评级,2024三季报点评:收入增速放缓,单季度管理费用率明显下降
加载更多
公司概况
公司名称:
爱美客技术发展股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-09-28
主营业务:
爱美客技术发展股份有限公司成是一家从事生物医用材料及生物医药产品研发与转化的国家高新技术企业。公司目前的主要产品为:基于透明质酸钠的系列皮肤填充剂、基于聚左旋乳酸的皮肤填充剂、面部埋植线产品等。公司透明质酸钠类注射产品2018至2021年在国产厂商中市场份额排名蝉联第一。公司已拥有八款获得国家药监局批准的Ⅲ类医疗器械产品,是国内获得国家药监局认证用于非手术医疗美容Ⅲ类医疗器械数量最多的企业。
发行价格:
118.27
{"stockData":{"symbol":"300896","market":"SZ","secType":"STK","nameCN":"爱美客","latestPrice":204.78,"timestamp":1732597830000,"preClose":202.2,"halted":0,"volume":1992484,"delay":0,"floatShares":208000000,"shares":302000000,"eps":6.6979,"marketStatus":"交易中","marketStatusCode":2,"change":2.58,"latestTime":"11-26 13:10:30","open":201.8,"high":208.55,"low":201.75,"amount":410000000,"amplitude":0.0336,"askPrice":204.84,"askSize":5,"bidPrice":204.67,"bidSize":1,"shortable":0,"etf":0,"ttmEps":6.6979,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732604400000},"adr":0,"adjPreClose":202.2,"symbolType":"stock","openAndCloseTimeList":[[1732584600000,1732591800000],[1732597200000,1732604400000]],"highLimit":222.42,"lowLimit":181.98,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":302437650,"pbRate":8.23,"roa":"--","roe":"23.11%","epsLYR":8.6,"committee":0.2,"marketValue":61933000000,"floatMarketCap":42689000000,"peRate":30.573763,"changeRate":0.0128,"turnoverRate":0.0096,"status":0},"requestUrl":"/m/hq/s/300896","defaultTab":"news","newsList":[{"id":"2484161294","title":"爱美客:产品具体上市时间需等待国家药监局审评结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2484161294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484161294?lang=zh_cn&edition=full","pubTime":"2024-11-20 17:00","pubTimestamp":1732093240,"startTime":"0","endTime":"0","summary":"证券之星消息,爱美客(300896)11月20日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司的肉毒素何时才能批复投入市场?爱美客董秘:尊敬的投资者您好,产品具体上市时间需等待国家药监局审评结果。感谢您的关注。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000028656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2484316362","title":"海通国际:淘天品牌驱动、抖音套盒热销 双11化妆品龙头多平台增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2484316362","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484316362?lang=zh_cn&edition=full","pubTime":"2024-11-20 15:46","pubTimestamp":1732088818,"startTime":"0","endTime":"0","summary":"海通国际主要观点如下:平台:抖音抢跑实现高增长,商品卡占比提升;淘天平台GMV贡献超50%,品牌共建创造增量据蝉魔方数据统计,10月8日至11月11日抖音双11化妆品销售额同比增长69.01%,其中护肤/彩妆类目销售额分别同比增长76.81%/61.44%,护肤类目消费增长创新高。淘天平台的销售增长得益于其“回归品牌价值导向”战略。历次大促来看,天猫平台TOP4品牌保持稳定,其中2024年双11中珀莱雅从预售首日至11月11日一直位列TOP1。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4535","LU0831103253.SGD","LU0608807946.USD","LU1642822792.SGD","300592","LU0828237940.HKD","001328","BK0170","MPNGY","300896","301381","LU0314109678.HKD","03690","BK1583","LU0541502299.USD","LU1568876335.HKD","600859","LU1688375341.USD","HBBD.SI","LU0449509016.USD","BK1610","600729","600612","BK1591","06181","LU0348805143.USD","LU0067412154.USD","LU0593848301.USD","601933","LU0577902371.SGD","09988","603605","600415","LU1515016050.SGD","SG9999002562.SGD","600694","LU0642271901.SGD","LU0588545904.SGD","BABA","BK1517","02367","09896","LU0011963245.USD","LU0648948544.HKD","LU2293587155.HKD","300866","89988","IE00B0JY6N72.USD","BK1589","BK4579"],"gpt_icon":0},{"id":"2483584896","title":"爱美客获得发明专利授权:“一种含有脱细胞生物组织材料的医用材料”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584896","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483584896?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:31","pubTimestamp":1731699078,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示爱美客新获得一项发明专利授权,专利名为“一种含有脱细胞生物组织材料的医用材料”,专利申请号为CN202310074159.7,授权日为2024年11月1日。本发明的方法简单易操作,制备的含有脱细胞生物组织材料的医用材料,降解周期可调,机械强度好,生物相容性优良。今年以来爱美客新获得专利授权19个,较去年同期减少了9.52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600006583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2483334190","title":"爱美客(300896)11月8日股东户数6.29万户,较上期增加1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483334190?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:04","pubTimestamp":1731661460,"startTime":"0","endTime":"0","summary":"证券之星消息,近日爱美客披露,截至2024年11月8日公司股东户数为6.29万户,较10月31日增加696.0户,增幅为1.12%。在医疗美容行业个股中,爱美客股东户数高于行业平均水平,截至11月8日,医疗美容行业平均股东户数为3.65万户。从股价来看,2024年10月31日至2024年11月8日,爱美客区间涨幅为11.39%,在此期间股东户数增加696.0户,增幅为1.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500026994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2482217815","title":"爱美客(300896)11月8日主力资金净卖出2.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482217815","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482217815?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:21","pubTimestamp":1731288071,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月8日收盘,爱美客报收于237.0元,下跌3.07%,换手率3.92%,成交量8.17万手,成交额19.5亿元。近5日资金流向一览见下表:爱美客融资融券信息显示,融资方面,当日融资买入2.95亿元,融资偿还2.75亿元,融资净买入2025.15万元,连续3日净买入累计2.66亿元。爱美客主营业务:生物医用材料及生物医药的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100002041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2482923228","title":"海通国际:给予爱美客增持评级,目标价位299.47元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482923228","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482923228?lang=zh_cn&edition=full","pubTime":"2024-11-10 15:30","pubTimestamp":1731223830,"startTime":"0","endTime":"0","summary":"海通国际证券集团有限公司孟科含,孙旭东近期对爱美客进行研究并发布了研究报告《24Q3盈利质量提升,关注消费复苏对业绩的催化》,本报告对爱美客给出增持评级,认为其目标价位为299.47元,当前股价为237.0元,预期上涨幅度为26.36%。2024年10月宝尼达2.0正式获批,用于纠正颏部后缩,并预计于25Q1上市。根据可比公司,我们认为爱美客作为行业龙头,品牌和渠道壁垒优势突出,给予2025年38XPE,下调目标价12%至每股HKD299.47。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111000000855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896"],"gpt_icon":0},{"id":"2481892914","title":"爱美客涨7.47%,德邦证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481892914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481892914?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:22","pubTimestamp":1730967744,"startTime":"0","endTime":"0","summary":"今日爱美客涨7.47%,收盘报244.5元。2024年8月22日,德邦证券研究员易丁依发布了对爱美客的研报《爱美客:中报业绩符合预期,25-26年储备多管线》,该研报对爱美客给出“买入”评级。此外,天风证券研究员何富丽,杨松,东吴证券研究员朱国广,吴劲草,冉胜男,张家璇,郗越近期也对该股发布了研报,同样给出“买入”评级。爱美客个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300896"],"gpt_icon":0},{"id":"2480096313","title":"“医美双雄”业绩承压:爱美客增速放缓,华熙生物变革阵痛","url":"https://stock-news.laohu8.com/highlight/detail?id=2480096313","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480096313?lang=zh_cn&edition=full","pubTime":"2024-11-04 19:44","pubTimestamp":1730720696,"startTime":"0","endTime":"0","summary":"但二者近期发布的三季报,却不及市场预期:爱美客营收增速创上市以来新低,华熙生物营收净利润双降。比如,2020年9月28日上市的爱美客,正面临增速放缓的难题。今年各季度,爱美客营收和利润增速呈现出一定的波动。毛利率方面,今年前三季度,爱美客的毛利率为94.8%,同比下降0.5个百分点。2024年三季报显示,华熙生物业绩呈现下滑态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104194905ab9e6a46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104194905ab9e6a46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","300896","688363","BK0229","BK0239"],"gpt_icon":0},{"id":"2480371877","title":"爱美客(300896)10月31日股东户数6.22万户,较上期增加0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480371877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480371877?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:06","pubTimestamp":1730711189,"startTime":"0","endTime":"0","summary":"证券之星消息,近日爱美客披露,截至2024年10月31日公司股东户数为6.22万户,较10月18日增加187.0户,增幅为0.3%。在医疗美容行业个股中,爱美客股东户数高于行业平均水平,截至10月31日,医疗美容行业平均股东户数为3.64万户。从股价来看,2024年10月18日至2024年10月31日,爱美客区间跌幅为3.44%,在此期间股东户数增加187.0户,增幅为0.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400022505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2479276910","title":"天风证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479276910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479276910?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:51","pubTimestamp":1730281914,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司杨松,何富丽近期对爱美客进行研究并发布了研究报告《24Q1-3归母净利润同增12%,高基数稳健过渡》,本报告对爱美客给出买入评级,当前股价为222.2元。 爱美客 公司发布24年三季报。24年Q3公司实现营收7.19亿,yoy+1.1%,归母净利4.65亿,yoy+2.13%。最新盈利预测明细如下:该股最近90天内共有30家机构给出评级,买入评级24家,增持评级6家;过去90天内机构目标均价为269.1。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000035483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","601162"],"gpt_icon":0},{"id":"2479249148","title":"A股医美概念股局部异动,朗姿股份直线涨停,芭薇股份、爱美客、贝泰妮等短线拉升。","url":"https://stock-news.laohu8.com/highlight/detail?id=2479249148","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479249148?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:16","pubTimestamp":1730268981,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300957","BK0048","BK0253","BK0107","159982","BK0070","BK0229","BK0251","BK0039","300896","002612","399300"],"gpt_icon":0},{"id":"2478648844","title":"爱美客(300896)10月24日主力资金净卖出1.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478648844?lang=zh_cn&edition=full","pubTime":"2024-10-25 09:22","pubTimestamp":1729819352,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月24日收盘,爱美客报收于208.7元,下跌3.82%,换手率2.53%,成交量5.28万手,成交额10.96亿元。近5日资金流向一览见下表:爱美客融资融券信息显示,融资方面,当日融资买入1.15亿元,融资偿还1.29亿元,融资净偿还1395.21万元。爱美客主营业务:生物医用材料及生物医药的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500009111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2478611079","title":"国元证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478611079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478611079?lang=zh_cn&edition=full","pubTime":"2024-10-25 08:27","pubTimestamp":1729816022,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对爱美客进行研究并发布了研究报告《2024三季报点评:单季度收入利润小幅增长,多品类布局静待新品》,本报告对爱美客给出买入评级,当前股价为208.7元。最新盈利预测明细如下:该股最近90天内共有31家机构给出评级,买入评级25家,增持评级6家;过去90天内机构目标均价为258.67。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500008130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","300896"],"gpt_icon":0},{"id":"2478697809","title":"爱美客(300896)2024年三季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2478697809","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478697809?lang=zh_cn&edition=full","pubTime":"2024-10-25 06:09","pubTimestamp":1729807760,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期爱美客发布2024年三季报。截至本报告期末,公司营业总收入23.76亿元,同比上升9.46%,归母净利润15.86亿元,同比上升11.79%。按单季度数据看,第三季度营业总收入7.19亿元,同比上升1.1%,第三季度归母净利润4.65亿元,同比上升2.13%。本报告期爱美客盈利能力上升,毛利率同比增幅0.89%,净利率同比增幅3.06%。持有爱美客最多的基金为招商国证生物医药指数C,目前规模为21.69亿元,最新净值0.4025,较上一交易日下跌0.49%,近一年下跌17.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500005339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896"],"gpt_icon":0},{"id":"2478538651","title":"开源证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478538651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478538651?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:55","pubTimestamp":1729785318,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司黄泽鹏,杨柏炜近期对爱美客进行研究并发布了研究报告《公司信息更新报告:三季度增长承压,期待后续管线落地打开成长空间》,本报告对爱美客给出买入评级,当前股价为208.7元。我们认为,公司产品规划较清晰,未来差异化管线陆续落地有望赋能长期成长,估值合理,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有31家机构给出评级,买入评级25家,增持评级6家;过去90天内机构目标均价为258.67。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400038993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","161027"],"gpt_icon":0},{"id":"2477634289","title":"民生证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477634289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477634289?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:55","pubTimestamp":1729778124,"startTime":"0","endTime":"0","summary":"民生证券股份有限公司刘文正,郑紫舟,褚菁菁近期对爱美客进行研究并发布了研究报告《2024年三季报点评:盈利能力持续提升,在研产品储备丰富》,本报告对爱美客给出买入评级,当前股价为208.7元。爱美客发布2024年三季度报告。2)再生材料:濡白天使持续放量,如生天使有望与濡白天使共同推动收入增长。最新盈利预测明细如下:该股最近90天内共有31家机构给出评级,买入评级25家,增持评级6家;过去90天内机构目标均价为258.67。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400038286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","161027"],"gpt_icon":0},{"id":"2477633756","title":"爱美客第三季度营收同比增长1.10% 多家券商下调业绩预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2477633756","media":"立刻财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477633756?lang=zh_cn&edition=full","pubTime":"2024-10-24 20:43","pubTimestamp":1729773780,"startTime":"0","endTime":"0","summary":"昨日晚间,爱美客发布2024年三季报。数据显示,公司前三季度合计实现营业收入23.76亿元,同比增长9.46%;归母净利润15.86亿元,同比增长11.79%;扣非归母净利润15.30亿元,同比增长9.66%。值得注意的是,爱美客第三季度业绩增速仍处于相对低位,实现营业收入7.19亿元,同比增长1.10%;归母净利润4.65亿元,同比增长2.13%;扣非归母净利润4.42亿元,同比下降4.35%。整体来看,多家券商研报表示,将下调对公司的业绩预测。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-24/doc-inctsmer6337028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300896"],"gpt_icon":0},{"id":"2477847504","title":"爱美客(300896.SZ)三季报业绩稳增、提质,长期增长潜力可观","url":"https://stock-news.laohu8.com/highlight/detail?id=2477847504","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477847504?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:55","pubTimestamp":1729763734,"startTime":"0","endTime":"0","summary":"短期“承压”不改长期潜力,增长质量持续提升。","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/110.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1214379","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2477350998","title":"中邮证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477350998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477350998?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:21","pubTimestamp":1729761699,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司近期对爱美客进行研究并发布了研究报告《高端消费景气度回落拖累Q3增速,保持高净利率》,本报告对爱美客给出买入评级,当前股价为208.7元。Q3分产品来看,溶液类注射产品延续上半年趋势,保持增长韧性;再生类产品受行业景气度及竞争加剧等因素增速大幅回落;其他凝胶产品有所下滑。最新盈利预测明细如下:该股最近90天内共有31家机构给出评级,买入评级25家,增持评级6家;过去90天内机构目标均价为258.67。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400030361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","161027"],"gpt_icon":0},{"id":"2477572403","title":"东吴证券给予爱美客买入评级,2024三季报点评:收入增速放缓,单季度管理费用率明显下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2477572403","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477572403?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:05","pubTimestamp":1729757100,"startTime":"0","endTime":"0","summary":"东吴证券10月24日发布研报称,给予爱美客(300896.SZ,最新价:208.7元)买入评级。评级理由主要包括:1)溶液类产品保持稳健增长,高端品类增长承压;2)三季度管理费用率明显下降,销售净利率提升;3)玻尿酸产品再获新证,司美格鲁肽注射液即将开展III期临床试验。风险提示:市场竞争加剧,新产品研发或推广不及预期的风险。AI点评:爱美客近一个月获得2份券商研报关注,买入1家。(文章来源:每日经济新闻)\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-24/doc-inctryqx5808023.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-24/doc-inctryqx5808023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["601555","300896"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-09-28","address":"北京市昌平区科技园区白浮泉路10号北控科技大厦4层416B室","stockEarnings":[{"period":"1week","weight":-0.0408},{"period":"1month","weight":-0.0673},{"period":"3month","weight":0.4594},{"period":"6month","weight":-0.0015},{"period":"1year","weight":-0.1248},{"period":"ytd","weight":-0.0307}],"companyName":"爱美客技术发展股份有限公司","boardCode":"AI0035","perCapita":"3369股","boardName":"专用设备制造业","registeredCapital":"30243万元","compareEarnings":[{"period":"1week","weight":-0.0181},{"period":"1month","weight":-0.0109},{"period":"3month","weight":0.1457},{"period":"6month","weight":0.0491},{"period":"1year","weight":0.0733},{"period":"ytd","weight":0.0971}],"survey":" 爱美客技术发展股份有限公司成是一家从事生物医用材料及生物医药产品研发与转化的国家高新技术企业。公司目前的主要产品为:基于透明质酸钠的系列皮肤填充剂、基于聚左旋乳酸的皮肤填充剂、面部埋植线产品等。公司透明质酸钠类注射产品2018至2021年在国产厂商中市场份额排名蝉联第一。公司已拥有八款获得国家药监局批准的Ⅲ类医疗器械产品,是国内获得国家药监局认证用于非手术医疗美容Ⅲ类医疗器械数量最多的企业。","serverTime":1732597833192,"listedPrice":118.27,"stockholders":"61860人(较上一季度减少1.65%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱美客,300896,爱美客股票,爱美客股票老虎,爱美客股票老虎国际,爱美客行情,爱美客股票行情,爱美客股价,爱美客股市,爱美客股票价格,爱美客股票交易,爱美客股票购买,爱美客股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}